Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04926168
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2021-06-08
Brief Title:
6 Months Adjuvant Temozolomide TMZ vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma GBM
Sponsor:
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
0
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 76258 |
Who Masked List: